These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

538 related articles for article (PubMed ID: 12325108)

  • 1. Subgroup analysis, covariate adjustment and baseline comparisons in clinical trial reporting: current practice and problems.
    Pocock SJ; Assmann SE; Enos LE; Kasten LE
    Stat Med; 2002 Oct; 21(19):2917-30. PubMed ID: 12325108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Misuse of baseline comparison tests and subgroup analyses in surgical trials.
    Bhandari M; Devereaux PJ; Li P; Mah D; Lim K; Schünemann HJ; Tornetta P
    Clin Orthop Relat Res; 2006 Jun; 447():247-51. PubMed ID: 16672904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A substantial and confusing variation exists in handling of baseline covariates in randomized controlled trials: a review of trials published in leading medical journals.
    Austin PC; Manca A; Zwarenstein M; Juurlink DN; Stanbrook MB
    J Clin Epidemiol; 2010 Feb; 63(2):142-53. PubMed ID: 19716262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Controlled randomized clinical trials].
    Jaillon P
    Bull Acad Natl Med; 2007; 191(4-5):739-56; discussion 756-8. PubMed ID: 18225427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statistical problems in the reporting of clinical trials. A survey of three medical journals.
    Pocock SJ; Hughes MD; Lee RJ
    N Engl J Med; 1987 Aug; 317(7):426-32. PubMed ID: 3614286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing quality of reports on randomized clinical trials in nursing journals.
    Parent N; Hanley JA
    Can J Cardiovasc Nurs; 2009; 19(2):25-39. PubMed ID: 19517902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements.
    Hernández AV; Steyerberg EW; Habbema JD
    J Clin Epidemiol; 2004 May; 57(5):454-60. PubMed ID: 15196615
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subgroup analyses in therapeutic cardiovascular clinical trials: are most of them misleading?
    Hernández AV; Boersma E; Murray GD; Habbema JD; Steyerberg EW
    Am Heart J; 2006 Feb; 151(2):257-64. PubMed ID: 16442886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relevance of subgroup-specific treatment effects: the Studies Of Left Ventricular Dysfunction (SOLVD) revisited.
    Parker AB; Yusuf S; Naylor CD
    Am Heart J; 2002 Dec; 144(6):941-7. PubMed ID: 12486418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primer: the fallacy of subgroup analysis.
    Guillemin F
    Nat Clin Pract Rheumatol; 2007 Jul; 3(7):407-13. PubMed ID: 17599075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring and reporting of the Women's Health Initiative randomized hormone therapy trials.
    Anderson GL; Kooperberg C; Geller N; Rossouw JE; Pettinger M; Prentice RL
    Clin Trials; 2007; 4(3):207-17. PubMed ID: 17715246
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    J Am Coll Cardiol; 2004 Aug; 44(3):720-32. PubMed ID: 15358046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.
    Grundy SM; Cleeman JI; Merz CN; Brewer HB; Clark LT; Hunninghake DB; Pasternak RC; Smith SC; Stone NJ;
    Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):e149-61. PubMed ID: 15297292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjusting for partially missing baseline measurements in randomized trials.
    White IR; Thompson SG
    Stat Med; 2005 Apr; 24(7):993-1007. PubMed ID: 15570623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subgroup analysis and other (mis)uses of baseline data in clinical trials.
    Assmann SF; Pocock SJ; Enos LE; Kasten LE
    Lancet; 2000 Mar; 355(9209):1064-9. PubMed ID: 10744093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is there evidence of implicit exclusion criteria for elderly subjects in randomized trials? Evidence from the GUSTO-1 study.
    Krumholz HM; Gross CP; Peterson ED; Barron HV; Radford MJ; Parsons LS; Every NR
    Am Heart J; 2003 Nov; 146(5):839-47. PubMed ID: 14597933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical issues in interpreting clinical trials.
    DeMets DL
    J Intern Med; 2004 May; 255(5):529-37. PubMed ID: 15078496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retrospective analyses of pooled data from CREST I and CREST II trials for treatment of cocaine dependence.
    Elkashef A; Holmes TH; Bloch DA; Shoptaw S; Kampman K; Reid MS; Somoza E; Ciraulo D; Rotrosen J; Leiderman D; Montgomery A; Vocci F
    Addiction; 2005 Mar; 100 Suppl 1():91-101. PubMed ID: 15730353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are leading medical journals following their own policies on CONSORT reporting?
    Folkes A; Urquhart R; Grunfeld E
    Contemp Clin Trials; 2008 Nov; 29(6):843-6. PubMed ID: 18703165
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical issues on the analysis of change in follow-up studies in dental research.
    Blance A; Tu YK; Baelum V; Gilthorpe MS
    Community Dent Oral Epidemiol; 2007 Dec; 35(6):412-20. PubMed ID: 18039282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.